Pharmaceutical

Novartis commits $23bn to US manufacturing amid tariff threats

Novartis plans new manufacturing sites and a second R&D hub as it shifts key operations to the US.

Apr 12, 2025 - 06:00
Novartis commits $23bn to US manufacturing amid tariff threats
Novartis plans new manufacturing sites and a second R&D hub as it shifts key operations to the US.
Read the original article

Tags:

Previous Article

Revolutionizing Quantum Dot Manufacturing with Continuous Flow and Eco-Friendly ...

Next Article

Pluri’s immune cell expansion technologies gain patents

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

SGNB-7H4V by Pfizer for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval

SGNB-7H4V by Pfizer for Human Epidermal Growth Factor R...

Jun 20, 2024

‘A target on my back’: New survey shows racism is a huge problem in nursing

‘A target on my back’: New survey shows racism is a hug...

May 31, 2023

AI startup Leucine raises $7m for drug manufacturing digital twin platform

AI startup Leucine raises $7m for drug manufacturing di...

Oct 17, 2023